A Bangladesh based, AIM listed Beximco Pharmaceuticals has announced that it would declare/approve 5% final Cash Dividend, 5% Stock Dividend and 10% Cash Dividend (already paid as interim dividend) for the period of 18 months ended on June 30, 2016; on its next Annual General Meeting that is to be held on Saturday at Beximco Industrial Park, Sarabo, Kashimpur in Bangladesh.
The Dhaka-based manufacturer and seller of generic pharmaceuticals has noted that the 5% Stock Dividend will be entitled by the Shareholders whose names appeared in the Share Register of the Company or in the Depository Register on the earlier declared record date i.e. May 12, 2016.
The company will also receive, consider and adopt the Audited Financial Statements of the Company for the period of 18 months ended on June 30, 2016 together with reports of the Auditors and the Directors thereon; at the AGM.